Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone

Free Abstracts

  Breast Cancer

  Free Subscription

Articles published in Semin Oncol

Retrieve available abstracts of 8 articles:
HTML format
Text format

Single Articles

    February 2017
  1. MARCUS PM, Durham DD
    Commentary on "Screening for breast cancer" by Peairs et al.
    Semin Oncol. 2017;44:73.
    PubMed     Text format    

  2. PEAIRS KS, Choi Y, Stewart RW, Sateia HF, et al
    Screening for breast cancer.
    Semin Oncol. 2017;44:60-72.
    PubMed     Text format     Abstract available

    October 2016
  3. COBAIN EF, Milliron KJ, Merajver SD
    Updates on breast cancer genetics: Clinical implications of detecting syndromes of inherited increased susceptibility to breast cancer.
    Semin Oncol. 2016;43:528-535.
    PubMed     Text format     Abstract available

    June 2016
  4. TAN AR
    Cutaneous manifestations of breast cancer.
    Semin Oncol. 2016;43:331-4.
    PubMed     Text format     Abstract available

    February 2016
  5. WOJTOWICZ ME, Dunn BK, Umar A
    Immunologic approaches to cancer prevention-current status, challenges, and future perspectives.
    Semin Oncol. 2016;43:161-72.
    PubMed     Text format     Abstract available

  6. WALCOTT FL, Patel J, Lubet R, Rodriguez L, et al
    Hereditary cancer syndromes as model systems for chemopreventive agent development.
    Semin Oncol. 2016;43:134-45.
    PubMed     Text format     Abstract available

  7. LAZZERONI M, DeCensi A
    Alternate dosing schedules for cancer chemopreventive agents.
    Semin Oncol. 2016;43:116-22.
    PubMed     Text format     Abstract available

  8. LEE O, Khan SA
    Novel routes for administering chemoprevention: local transdermal therapy to the breasts.
    Semin Oncol. 2016;43:107-15.
    PubMed     Text format     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Breast Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.